Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| KCT-0809 ophthalmic solution, low dose | Experimental |
| |
| KCT-0809 ophthalmic solution, medium dose | Experimental |
| |
| KCT-0809 ophthalmic solution, high dose | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| KCT-0809 | Drug |
| ||
| KCT-0809 |
| Measure | Description | Time Frame |
|---|---|---|
| Corneal-conjunctival staining scores | 4 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Katsumi Hontani | Kissei Pharmaceutical Co., Ltd. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Japan | Tohoku, Kanto, Chubu, Kansai, Kyushu Region | Japan |
Not provided
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| D003316 | Corneal Diseases |
| D003229 | Conjunctival Diseases |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| KCT-0809 | Drug |
|
| Placebo | Drug |
|